Immuneering (IMRX) Change in Acquisitions & Divestments (2022 - 2026)

Immuneering's Change in Acquisitions & Divestments history runs 4 years deep, the most recent figure standing at $9.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 14.29% YoY), while the FY2024 annual figure was $31.9 million, down 38.95% from the prior year.
• Change in Acquisitions & Divestments was $9.0 million for Q1 2026 at Immuneering, up from $5.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $32.3 million in Q2 2022 to a low of $5.0 million in Q3 2023.
• Historically, Change in Acquisitions & Divestments has averaged $15.5 million across 4 years, with a median of $19.0 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments sank 74.03% in 2023, then advanced 12.79% in 2024.
• A 4-year view of Change in Acquisitions & Divestments shows it stood at $20.6 million in 2022, then decreased by 7.52% to $19.0 million in 2023, then sank by 71.13% to $5.5 million in 2024, then surged by 63.64% to $9.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $9.0 million (Q1 2026), $5.5 million (Q4 2024), and $5.0 million (Q2 2024), per Business Quant data.